Fibroblast Growth Factor 23 in COVID-19: An Observational Study

Athena Myrou1, Theodoros Aslanidis2, Keli Makedou3

  • 1Department of Internal Medicine, American Hellenic Educational Progressive Association (AHEPA) University Hospital, Thessaloniki, GRC.

Cureus
|August 28, 2023
PubMed
Summary

Fibroblast growth factor 23 (FGF23) levels in COVID-19 patients showed variations, but no significant correlation was found with common laboratory markers. Further research is needed to establish a reliable link between FGF23 and COVID-19 severity.